Page last updated: 2024-11-02

oxaprozin and Bullous Dermatoses

oxaprozin has been researched along with Bullous Dermatoses in 3 studies

Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
oxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"We report two cases of pseudoporphyria caused by naproxen and oxaprozin."4.80Pseudoporphyria induced by propionic acid derivatives. ( Al-Khenaizan, S; Sasseville, D; Schechter, JF, 1999)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ingrish, G1
Rietschel, RL1
Abate, KL1
Malkinson, FD1
Al-Khenaizan, S1
Schechter, JF1
Sasseville, D1

Reviews

1 review available for oxaprozin and Bullous Dermatoses

ArticleYear
Pseudoporphyria induced by propionic acid derivatives.
    Journal of cutaneous medicine and surgery, 1999, Volume: 3, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Drug Eruptions; Female; Humans;

1999

Other Studies

2 other studies available for oxaprozin and Bullous Dermatoses

ArticleYear
Oxaprozin-induced pseudoporphyria.
    Archives of dermatology, 1996, Volume: 132, Issue:12

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Drug Eruptions; Humans; Male; Midd

1996
Toxic eruption in a woman with chronic arthritis.
    Archives of dermatology, 1999, Volume: 135, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Basement Membrane; Chronic Disease; Drug Eruptio

1999